I Am Bhojpuriya

Author: Sutun Nayak

  • Capitol Hospital Urology Experts Advise: Don’t Ignore the Signs of Prostate Enlargement

    Capitol Hospital Urology Experts Advise: Don’t Ignore the Signs of Prostate Enlargement

    New Delhi [India], March 19: As men age, their bodies go through many natural changes. One such change, often less spoken about, is the enlargement of the prostate gland. This condition, known as Benign Prostatic Hyperplasia (BPH), is extremely common, especially in men above 50 years of age. While the term may sound complicated, it simply means a non-cancerous (benign) growth of the prostate.
    • Awareness is the first step towards better men’s health
    • It is not cancer, but timely care can improve quality of  life.
    • Most men over 50 face it — learn the signs and seek timely care !

    Doctors at Capitol Hospital frequently see men experiencing urinary symptoms related to prostate enlargement. With timely diagnosis and modern treatment facilities available at Capitol Hospital, most patients are able to manage their symptoms effectively and maintain a good quality of life.

    What is the Prostate?

    The prostate is a small gland, about the size of a walnut, located just below the bladder. Its main job is to produce fluid that helps nourish and transport sperm. However, as men grow older, the gland often increases in size. When this happens, it can press against the urinary passage (urethra) and cause troublesome symptoms.

    Common Symptoms of Prostate Enlargement

    Men with BPH may notice changes in their urination habits, such as:

    • Frequent urge to pass urine, especially at night
    • Weak or interrupted urine flow
    • Feeling that the bladder is not completely empty
    • Difficulty in starting urination
    • Dribbling at the end of urination

    These symptoms may start gradually but can worsen over time if ignored.

    Is it Cancer?

    The good news is that prostate enlargement in BPH is not cancer. However, the symptoms can significantly affect daily life and sleep quality. Ignoring the condition may sometimes lead to complications like repeated urine infections, bladder stones, or kidney problems. That is why timely consultation with a urologist is important.

    Diagnosis and Treatment

    A urologist can usually diagnose BPH with a simple consultation, examination, and some basic tests. At Capitol Hospital, advanced diagnostic facilities and experienced urology specialists help in identifying the condition early and guiding patients towards the most suitable treatment.

    Treatment depends on the severity of symptoms:

    • Lifestyle changes – reducing evening fluid intake, limiting caffeine and alcohol, and regular exercise.
    • Medications – to relax the prostate muscles or reduce its size.
    • Minimally invasive or surgical options – for men with severe symptoms not relieved by medicines. Modern treatments are safe, effective and even with advancements by use of laser these operations are without any incision or suture or wound on patients body, thus helping men return to normal life quickly.

    Advanced Care and Expertise

    At Capitol Hospital, the Department of Urology is equipped with advanced diagnostic facilities and modern treatment options for prostate-related conditions. Specialists at the hospital regularly manage cases of prostate enlargement using minimally invasive and laser-based procedures, which help reduce hospital stay and enable faster recovery for patients.

    “Many patients believe that urinary problems are simply a part of aging and cannot be treated,” says Dr. Vikrant Mahajan. “But with the availability of modern medicines and advanced surgical techniques, most men can experience significant relief and improved quality of life.”

    Why Awareness Matters

    Many men feel shy or embarrassed to discuss urinary problems. They may consider these issues a “normal part of aging” and delay seeking help. Awareness is the first step. BPH is common, treatable, and nothing to be ashamed of. Talking openly about it and consulting a doctor early can prevent complications and improve quality of life.

    Take-Home Message

    If you are a man over 50 and notice changes in your urination habits, do not ignore them. Prostate enlargement is common, but timely care makes a big difference. Experts at Capitol Hospital emphasize that early consultation and proper treatment can help men stay healthy and active for years to come.

    URL :https://www.capitolhospital.com/https://www.capitolhospital.com/

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Wooden Street Exclusively Launches the Veda Collection to Bring Timeless Indian Philosophy into Modern Living

    Wooden Street Exclusively Launches the Veda Collection to Bring Timeless Indian Philosophy into Modern Living

    New Delhi [India], March 19: Wooden Street, one of India’s leading furniture and home décor brands, proudly announces the launch of its newest furniture collection – the Veda Collection, a thoughtfully designed range inspired by the philosophy of timeless Indian living.

    Rooted in the idea of balance, harmony, and enduring craftsmanship, the Veda Collection translates ancient Indian design sensibilities into contemporary furniture for modern homes. The collection combines solid wood, natural textures, and refined detailing to create pieces that feel both grounded in tradition and relevant to today’s lifestyles.

    With an emphasis on thoughtful design and proportion, the Veda Collection celebrates the beauty of materials such as solid wood, cane, and brass accents. Each element is crafted to create furniture that feels calm, structured, and long-lasting — echoing the essence of timeless Indian craftsmanship while seamlessly fitting into contemporary interiors.

    Wooden Street Exclusively Launches the Veda Collection to Bring Timeless Indian Philosophy into Modern Living-PNN

    The collection introduces a curated range of furniture across living, dining, and sleep categories, named as Veda Sleep, Veda Dining & Veda Living, which includes sofas, dining tables, beds, lounge chairs, benches, and storage pieces. Each design reflects Wooden Street’s commitment to quality, functionality, and aesthetics, ensuring that every product enhances both comfort and style within modern homes.

    Every piece in the Veda Collection is crafted in Wooden Street’s in-house manufacturing units, reflecting the brand’s focus on high-quality craftsmanship and Made-in-India production. The designs bring together modern functionality and heritage inspiration, creating furniture that is built not just for everyday use but for long-lasting presence in homes.

    Speaking on the launch, Lokendra Ranawat, Co-Founder & CEO, WoodenStreet, shared, “The Veda Collection represents a deeper design philosophy for us — one that celebrates balance, simplicity, and timelessness. With this collection, we wanted to create furniture that resonates with Indian roots while meeting the needs of contemporary homes.”

    Over the years, Wooden Street has built a strong presence across India with a rapidly growing omnichannel network and a commitment to innovative furniture design. The launch of the Veda Collection further strengthens the brand’s vision of bringing thoughtfully crafted furniture to modern Indian homes.

    Customers can now explore the Veda Collection across Wooden Street’s website and experience stores nationwide, discovering furniture that reflects the philosophy of timeless design while elevating everyday living spaces.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Supreme Power Equipment Limited Secures Orders Worth Rs 113.61 Cr

    Supreme Power Equipment Limited Secures Orders Worth Rs 113.61 Cr

    Chennai (Tamil Nadu) [India], March 18: Supreme Power Equipment Limited (SPEL) (NSE: SUPREMEPWR), one of India’s leading manufacturers of power and distribution transformers, has secured new orders aggregating to approximately ₹113.61 Cr, reinforcing its strong position in the domestic power equipment sector.

    The Company has received a ₹35.76 Cr order from Kerala State Electricity Board (KSEB) for the supply of 25 MVA, 110/33 KV power transformers, with execution expected within approximately 14 months.

    Additionally, SPEL has secured orders from Tamil Nadu Power Distribution Company amounting to ₹6.54 Cr for the supply of 500 KVA / 11 KV distribution transformers, to be executed within approximately 12 months.

    Further strengthening its order book, ₹71.31 Cr worth of transformer orders from Tamil Nadu Power Distribution Company have been awarded to Danya Electric Company, a partnership firm in which SPEL holds 90% stake. These orders include the supply of distribution transformers across multiple capacities—250 KVA / 11 KV, 63 KVA / 22 KV, 16 KVA / 11 KV, and 100 KVA / 11 KV, with execution timelines ranging from 12 to 18 months.

    With these order wins, the Company continues to witness strong demand from state utilities, highlighting its proven execution track record, product quality, and customer trust.

    The successful commissioning and operationalization of SPEL’s new transformer manufacturing facility significantly enhances its production capacity and operational efficiency. This expanded capability positions the Company to execute large-scale and diversified orders efficiently, while maintaining high standards of quality and timely delivery.

    These developments underline SPEL’s continued growth momentum and its commitment to supporting India’s expanding power infrastructure with reliable and advanced transformer solutions.

    Commenting on the development, Mr. Vee Rajmohan, Chairman and Managing Director of Supreme Power Equipment Limited, said, “We are pleased to secure these significant orders aggregating to over ₹113 Cr from key state utilities, which reflects the continued trust placed in our product quality, execution capabilities, and long-standing relationships. These orders further strengthen our order book visibility and reinforce our positioning in the domestic transformer market.

    Importantly, with the successful operationalization of our new transformer manufacturing facility, we are well-equipped to execute larger and more diverse orders with improved efficiency and shorter turnaround times. This enhanced capacity, coupled with our strong engineering capabilities, positions us well to capitalize on the growing opportunities in India’s power infrastructure sector.”

    Disclaimer: This article is for informational purposes only and does not constitute financial advice.

  • Cupid Limited Announces Development of Nitrile Female Condom Targeting Global Monopoly Segment and Strategic Branding Alignment: “Made in India” with “Japanese Quality”

    Cupid Limited Announces Development of Nitrile Female Condom Targeting Global Monopoly Segment and Strategic Branding Alignment: “Made in India” with “Japanese Quality”

    Mumbai (Maharashtra) [India], March 18: Cupid Limited (BSE: 530843 | NSE: CUPID), Cupid Limited, India’s leading manufacturer and exporter of male and female condoms, today announced the commencement of its development programme for a Nitrile (NBR) Female Condom, aimed at entering and diversifying the currently single supplier global nitrile female condom market. The Company also announced a strategic branding alignment centered on the proposition “Made in India” with “Japanese Quality,” reinforcing its commitment to combining India’s strong manufacturing capabilities with globally recognized standards of precision, reliability, and product excellence.

    Addressing a Long-Standing Single-Supplier Market

    The global female condom market was estimated to be valued at approximately USD 770 million in 2024 and is projected to exceed USD 1.2 billion by 2030. Within this market, the nitrile female condom segment, a premium latex-free category, has historically been supplied by only one manufacturer worldwide, which produces the FC2 Female Condom. With the increasing demand from global procurement agencies for supply diversification, Cupid’s entry into nitrile female condom manufacturing represents a significant strategic opportunity.

    Purpose-Built Dual-Polymer Manufacturing Facility

    Cupid’s new manufacturing facility, part of the Company’s previously announced expansion programme, has been architecturally and technically designed to accommodate dual-polymer dipping lines operating concurrently. This configuration allows the facility to manufacture:

    • Natural Rubber Latex (NRL) condoms
    • Nitrile Butadiene Rubber (NBR) condoms

    on dedicated production lines within the same facility, ensuring no cross-contamination and optimal production efficiency. With this development, Cupid becomes the only condom manufacturer in India with integrated dual-polymer dipping capability, enabling the Company to serve:

    • the established NRL male condom market
    • the NRL female condom market
    • the premium nitrile female condom segment

    Upon full commissioning, the expanded new facility is expected to support annual production capacity of approximately:

    • 1.25 billion male condoms
    • 125 million female condoms

    Development Programme and Technical Approach

    Cupid has initiated a structured research and development programme for the nitrile female condom, supported by international technical expertise with deep domain experience in:

    • NBR compound formulation
    • dipping technology
    • female condom design engineering

    The programme will focus on formulation optimization, coagulant engineering, dipping parameters, and comprehensive validation testing, in accordance with ISO 25841:2017 standards for female condoms.

    Cupid already possesses a strong regulatory foundation in the segment, with its NRL-based female condom currently holding WHO/UNFPA prequalification and being supplied to more than 50 countries globally.

    Strategic Rationale

    Cupid’s entry into the nitrile female condom segment is driven by several compelling strategic factors:

    1. Supply Diversification

    Global procurement agencies such as UNFPA and national ministries of health have long sought alternative suppliers to reduce reliance on a single manufacturer.

    2. Premium Product Segment

    Nitrile female condoms typically command 25–35% higher prices than latex alternatives due to their key advantages:

    • Latex-free material (suitable for latex-allergic users)
    • Thinner construction
    • Lower odor profile
    • More natural heat conduction

    3. Technical and Regulatory Barrier to Entry

    The specialized raw material supply chain, formulation expertise, and regulatory requirements create significant barriers to entry. Cupid’s existing technical capabilities and global distribution experience provide a strong platform to compete effectively in this segment.

    Commenting on the Development, Mr. Durgesh Garg, Chief Operating Officer said, “For over two decades, the nitrile female condom segment has largely been served by a single supplier. This has limited procurement flexibility for global health agencies and restricted access to latex-free protection for many women worldwide. Cupid is uniquely positioned to address this gap.

    Our new manufacturing plant has been purpose-designed from the ground up to support simultaneous dipping of two distinct polymer systems Natural Rubber Latex and Nitrile. This dual-polymer capability will allow us to offer global procurers a credible, quality-assured second source for nitrile female condoms.”

    Additionally, Cupid Limited has also announced a strategic branding alignment centered on the powerful proposition “Made in India” with “Japanese Quality.”

    This initiative reflects Cupid Limited’s commitment of combining India’s strong manufacturing capabilities with globally recognized standards of precision, reliability, and product excellence. The initiative has been made possible through a collaboration with Asia’s oldest latex condom manufacturing company, further strengthening Cupid’s technological capabilities and reinforcing its global positioning.

    The new branding focus is designed to resonate strongly with both Indian consumers and the Company’s valued corporate OEM (Original Equipment Manufacturer) partners worldwide. The initiative also marks a milestone in Cupid Limited’s 28-year journey in condom manufacturing, underscoring the Company’s continued focus on quality, reliability, and innovation.

    Through this strategic positioning, Cupid Limited aims to achieve multiple objectives:

    For Cupid Brand Consumers
    The initiative is intended to strengthen consumer confidence in the Cupid brand, aligning Indian consumers with an elevated standard of trust, safety, and product reliability.

    For Corporate OEM Customers
    Cupid Limited will extend the same assurance of quality and reliability to its global OEM partners, further reinforcing its position as a dependable and trusted global supplier of high-quality condom products.

    With this initiative, Cupid Limited continues to strengthen its position as a trusted global manufacturer delivering world-class quality products, while also highlighting India’s growing role as a reliable manufacturing hub for healthcare and personal wellness products.

    Commenting on the Development, Mr. Dhruba Goswami, Business Development Head said, “For over two decades, the nitrile female condom segment has largely been served by a single supplier. This has limited procurement flexibility for global health agencies and restricted access to latex-free protection for many women worldwide. Cupid is uniquely positioned to address this gap.

    Our new manufacturing plant has been purpose-designed from the ground up to support simultaneous dipping of two distinct polymer systems Natural Rubber Latex and Nitrile. This dual-polymer capability will allow us to offer global procurers a credible, quality-assured second source for nitrile female condoms.”

    Disclaimer: This article is for informational purposes only and does not constitute financial advice.

  • Chandan Healthcare Enters Maharashtra and West Bengal; Launches Mumbai, Kolkata & Kota Diagnostic Centres

    Chandan Healthcare Enters Maharashtra and West Bengal; Launches Mumbai, Kolkata & Kota Diagnostic Centres

    lucknow (Uttar Pradesh) [India], March 19:: Chandan Healthcare Limited (NSE – CHANDAN), – Chandan Healthcare Limited, one of the leading diagnostic and healthcare service providers in North India, has expanded its presence with the launch of new diagnostic centres in Mumbai and Kolkata, marking its entry into Maharashtra and West Bengal. The Company has also commenced diagnostic operations in Kota (Rajasthan), further strengthening its growing network across India.

    The Mumbai and Kolkata centres are equipped to offer comprehensive diagnostic services, including pathology and blood investigations, along with advanced tests such as TMT, ECG, EEG, and PFT. These centres are designed to cater to a wide range of patient requirements while also supporting diagnostic needs of associated partner centres across the network, enabling integrated and efficient service delivery.

    The Company plans to further enhance capabilities at these facilities by introducing additional diagnostic services such as X-Ray and Bone Mineral Density (BMD) in due course, strengthening its service portfolio and improving overall diagnostic accessibility.

    In addition, Chandan Healthcare has commenced diagnostic operations in Kota (Rajasthan) as part of its ongoing rollout under the previously announced five-year strategic partnership with Jeena Sikho Lifecare Limited. As the exclusive diagnostic partner for Jeena Sikho hospitals and clinics, the Company will continue to expand diagnostic services across additional facilities under this collaboration.

    This expansion is expected to strengthen the Company’s overall diagnostic network, improve access to quality healthcare services, and support higher patient volumes. The launch of centres in Mumbai and Kolkata enhances its presence in key urban markets, while the Kota operations support execution of its partnership-led expansion strategy and long-term growth plans.

    Commenting on the development, Mr. Amar Singh, Promoter and Managing Director of Chandan Healthcare Limited, said, “We are pleased to expand our presence into Maharashtra and West Bengal, along with the rollout of operations under the Jeena Sikho partnership in Kota. This aligns with our strategy to build a scalable and integrated diagnostic network

    We remain focused on enhancing accessibility, strengthening our service capabilities, and expanding our presence across high-growth regions. At the same time, we will continue to invest in expanding our diagnostic offerings and supporting our partner network to deliver consistent and high-quality healthcare services.”

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • HEC Infra Projects Limited Secures Rs 36.50 Cr EPC Order for 10.4 MW Solar Power Plant

    HEC Infra Projects Limited Secures Rs 36.50 Cr EPC Order for 10.4 MW Solar Power Plant

    Ahmedabad (Gujarat) [India], March 18: HEC Infra Projects Limited (HEC Infra Projects Limited, The Company), (NSE Code: HECPROJECT), one of the leading EPC players specialising in Electrical, Mechanical, and Instrumentation works, is pleased to announce that the Company has secured a work order worth approximately ₹36.50 Cr from M/S Siemens Financial Services Private Limited. The order has been awarded for the development of a 10.4 MW Solar Power Plant Generation System.

    The scope of the project includes engineering, procurement and construction of the solar power plant, covering the installation and commissioning of the complete solar power generation system along with associated infrastructure. The project is scheduled to be completed within a period of 6 months.

    This project reflects the increasing demand for renewable energy infrastructure and highlights the growing opportunities in India’s solar power sector driven by the country’s transition towards clean and sustainable energy sources.

    Going forward, HEC Infra Projects Limited intends to actively participate in similar EPC opportunities in the renewable energy sector while continuing to expand its presence across solar and power infrastructure projects in India.

    On the receipt of the order, Mr. Gaurang Shah, Managing Director of HEC Infra Projects Limited said, “We are pleased to secure this EPC order for the development of a 10.4 MW Solar Power Plant Generation System. The project represents an important addition to our project portfolio and reflects the growing opportunities emerging in the solar power sector.

    We remain committed to executing the project within the stipulated timeline of 6 months while maintaining high standards of quality and operational efficiency. With India continuing to expand its solar power capacity as part of the clean energy transition, the sector presents strong long-term growth potential.”

    Disclaimer: This article is for informational purposes only and does not constitute financial advice.

  • GTE 2026: Ultimate Marketplace for Garment Technology and Complete Ecosystem for Apparel Production

    GTE 2026: Ultimate Marketplace for Garment Technology and Complete Ecosystem for Apparel Production

    New Delhi [India], March 19: India’s garment manufacturing sector is entering a decisive phase of technological transformation, and leading this momentum is the 39th edition of the Garment Technology Expo (GTE) 2026, scheduled from 20–23 March 2026 at the India Expo Centre & Mart, Delhi–NCR. With a legacy of 38 successful editions and more than 25 years of industry trust, GTE has established itself as one of Southeast Asia’s most influential B2B platforms for garment manufacturing technologies.

    Supported by the Ministry of Textiles and the Ministry of Micro, Small and Medium Enterprises, GTE 2026 aims to help garment manufacturers modernise production lines, adopt automation and strengthen global competitiveness. As India moves towards its goal of building a $350-billion textile and apparel economy by 2030, the expo will showcase advanced machinery, digital manufacturing systems and next-generation solutions from over 20 countries, enabling manufacturers to upgrade productivity, precision and scale.

    A major highlight of the exhibition is its co-location with Lace & Trims Show 2026, a dedicated sourcing platform for essential garment components. From laces, trims, labels, fasteners, embellishments and accessories to allied inputs, the show will bring together key suppliers and manufacturers of critical production materials. Together, GTE and Lace & Trims Show create a comprehensive marketplace covering the entire garment manufacturing value chain, enabling buyers to explore the latest materials, sourcing solutions and design innovations shaping apparel production.

    Adding valuable industry insight, trend forecasts in apparel production will be showcased by the National Institute of Fashion Technology, offering manufacturers guidance on emerging design directions, production practices and evolving market demands.

    The exhibition will feature a wide spectrum of technologies, including sewing and embroidery machines, cutting, spreading and laying equipment, digital textile printing systems, CAD/CAM software, dyeing, finishing and laundry technologies, testing equipment and quality control solutions. Live demonstrations and technology launches will help manufacturers evaluate innovations that improve efficiency, quality and cost optimisation.

    Commenting on the industry outlook, Dr. Rakesh Kumar said that the Indian garment industry is witnessing increasing momentum in technology adoption, driven by infrastructure development, policy support and growing global demand. Platforms such as GTE provide manufacturers with the opportunity to explore advanced solutions and strengthen their competitiveness in international markets. GTE is about empowering Indian factories with the right technologies and insights to enhance productivity, improve quality and remain competitive on a global stage.

    Shri Inderjit Singh Sahni, Founder & Managing Director, Garment Technology Expo (GTE), shared his thoughts, saying,“When Garment Technology Expo was conceived in 2001, the vision was clear—to bring world-class garment manufacturing technology within India’s reach. At a time when discovering the latest innovations meant travelling overseas, GTE created a trusted platform where global technology leaders could showcase their solutions live for Indian manufacturers. GTE has steadily evolved over the years. What began as a machinery-focused exhibition has today transformed into a comprehensive industry platform. Our focus now goes beyond showcasing equipment—we aim to enable automation, sustainability, digitalisation and future-ready manufacturing.

    Echoing this perspective, Rathi Sahni highlighted that rapid advancements in automation, digitalisation and smart production technologies are redefining garment manufacturing. She noted that GTE 2026 will serve as a crucial meeting point where manufacturers can discover innovations, connect with technology providers and prepare their businesses for the next phase of industry growth. As the industry continues to evolve, GTE remains committed to driving this transformation and supporting the growth of a stronger, smarter and more resilient garment manufacturing ecosystem.

    Jointly organised by Garment Technology Expo and India Exposition Mart Ltd., GTE 2026 offers a world-class platform for garment manufacturers, exporters, buying houses and sourcing professionals to connect with global technology leaders.

    GTE 2026 – Best Today, Still Better Tomorrow.

  • Digital Healthcare Platform Jivo Care Launches ‘Global Wellness Program’ to Eradicate Fragmented Care

    Digital Healthcare Platform Jivo Care Launches ‘Global Wellness Program’ to Eradicate Fragmented Care

    Gurugram (Haryana) [India], March 19: Jivo Care, an integrated digital healthcare platform, has launched its comprehensive Global Wellness Program. Designed as the company’s central “Hero Program,” this all-in-one ecosystem unifies proactive health frameworks for corporate workplaces, educational institutions, and elder care centers.

    The platform focuses on helping solve major macro-health issues, including lifestyle-related diseases, which account for over 60% of all deaths in India, and the worldwide productivity loss of $1 trillion due to anxiety and depression. Instead of relying on multiple individual healthcare visits, Jivo Care provides a single tech platform to meet these challenges. Supported by a proprietary digital app and a web portal with over 1,000 self-help resources, the program is staffed with a 24/7 Care Coordinator to assist the users of the program, and provides them with an organised, clinical plan of care, which includes both pre-and post-treatment follow-up.

    Jivo Care

    Discussing the milestone, Harshwardhan Singh Choudhary, CEO of Jivo Care, stated, “Healthcare should not start at the emergency department. Our vision with Jivo Care is to make preventive healthcare accessible, guided, and integrated into everyday life so individuals can stay healthier physically and mentally.”

    The program provides evidence-based clinical frameworks which support individuals through three key development stages. For corporations, it addresses the hidden costs of absenteeism and presenteeism through personalised nutrition and stress-reduction programming. For educational institutions, it provides critical emotional support to students facing increased academic pressure, while also providing critical emotional support for educators. For elderly care centres, the program prevents social isolation and cognitive decline by providing structured psychological support and nutritional programming as part of the physical environment where they reside.

    Shubham Sharma, COO of Jivo Care, commented on the operational scale of the program, “Corporate wellness needs structure, continuity, and personalisation. By combining mental health, nutrition, and coordinated medical support, we aim to simplify healthcare for employees while helping organisations build physical and mental well-being ecosystems.”

    Following this launch, the company plans to expand its integrated healthcare model into international markets and develop its own end-to-end physical hospital network to deliver comprehensive support.

    “Much like infrastructure, healthcare requires strong foundations and long-term vision. Proactive healthcare is focused on building systems that support people before challenges arise.

    said Harendra Singh, Group Chairman and Patron of Jivo Care. “Jivo Care’s approach is an important step towards creating a structured, technology-driven healthcare ecosystem focused on early care and sustainable health outcomes.”

    About Jivo Care

    Jivo Care is an integrated digital healthcare platform dedicated to making proactive, preventive wellness accessible to all. Through its comprehensive Global Wellness Program, the company combines technology with human-led care coordination to provide structured mental health, nutritional, and medical support, enabling a seamless healthcare journey for corporations, educational institutions, and elder care communities.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Arvore Healthcare Reinforces Legacy Leadership in Orthopedic Implants, Strengthening Its Position as a Trusted Partner to Surgeons Across India and Global Markets

    Arvore Healthcare Reinforces Legacy Leadership in Orthopedic Implants, Strengthening Its Position as a Trusted Partner to Surgeons Across India and Global Markets

    New Delhi [India], March 19:  Arvore Healthcare, a long-established and trusted name in the Indian orthopedic industry, continues to reinforce its leadership with a deeply integrated and time-tested Orthopedic Implants Division, built on years of clinical trust, engineering excellence, and consistent surgical performance.

    With a strong legacy of serving hospitals and surgeons across the country, Arvore Healthcare has evolved into a comprehensive solutions provider spanning Orthopedic Trauma Implants (Nails, Plates, and Screws), Arthroscopy, Spine Implants, and Arthroplasty systems—delivering reliability that has stood the test of time in operating rooms.

    A Proven Backbone in Orthopedic Trauma Care

    Arvore’s Trauma Implant portfolio has long been regarded as a dependable choice among orthopedic surgeons, offering a wide range of intramedullary nails, anatomically contoured plates, and high-precision screws. Engineered for consistent fixation strength and predictable outcomes, these systems have been extensively used in managing complex fractures across diverse clinical settings.

    The division’s continued focus on design refinement and metallurgical precision ensures implants that perform reliably under demanding surgical conditions—reinforcing surgeon confidence built over years of usage.

    Trusted Solutions in Arthroscopy and Sports Medicine

    In the evolving domain of minimally invasive orthopedic procedures, Arvore Healthcare’s Arthroscopy range reflects a mature understanding of surgical needs developed over time. The company offers advanced solutions for ligament reconstruction, soft tissue fixation, and joint stabilization—supporting surgeons in achieving precision with minimal tissue disruption.

    With a track record of dependable performance, Arvore’s arthroscopy systems contribute to faster recovery cycles and improved patient satisfaction.

    Comprehensive Spine Portfolio Backed by Clinical Confidence

    Arvore Healthcare’s Spine Implants division has steadily built credibility by delivering consistent results in spinal fixation and stabilization procedures. Designed to address degenerative conditions, trauma cases, and deformity corrections, these systems combine structural strength with surgical versatility.

    The company’s long-standing engagement with spine specialists has enabled continuous product evolution aligned with real-world clinical demands.

    Arthroplasty Systems Designed for Long-Term Performance

    In joint replacement, Arvore’s Arthroplasty solutions for hip and knee procedures are known for their durability, anatomical precision, and sustained clinical outcomes. Developed through years of experience and surgeon feedback, these systems are designed to restore mobility while ensuring long-term implant performance.

    Legacy of Trust, Vision for the Future

    Arvore Healthcare’s sustained presence in the orthopedic sector is anchored in its commitment to quality manufacturing, stringent compliance with international standards, and deep-rooted relationships with the medical fraternity.

    A company spokesperson stated, “Our strength lies in the trust we have built over the years. Surgeons rely on Arvore not just for products, but for consistency, reliability, and clinical assurance. As we move forward, we continue to build on this legacy while expanding our global reach.”

    With an expanding footprint across international markets and a reputation grounded in performance, Arvore Healthcare stands as a symbol of enduring trust and capability in orthopedic implants—where experience meets innovation to deliver dependable surgical outcomes.

    About Arvore Healthcare Arvore Healthcare is a well-established orthopedic solutions provider with a strong presence in India and growing global markets. Known for its quality-driven approach and long-standing industry experience, the company continues to support surgeons with reliable, high-performance medical devices across key orthopedic segments.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • IPS Academy Student Bags Top Spot in Speech Contest, Set to Shine at International Management Conclave

    IPS Academy Student Bags Top Spot in Speech Contest, Set to Shine at International Management Conclave

    Our student, Urvashi Patel received the trophy for winning the speech competition at IMA.

    Indore (Madhya Pradesh) [India], March 19: In a proud moment for higher education in the region, Ms. Urvashi Patel, a BBA II Year student from IPS Academy, IBMR, North Campus – a DAVV affiliated college on the Indore-Ujjain Road – has clinched first place in a fiercely contested speech competition organized by the prestigious Indore Management Association (IMA).

    Outshining competitors from 25 other renowned colleges, Ms. Urvashi’s eloquent delivery and insightful perspectives earned her this coveted honor. Her victory paves the way for an even bigger stage: she has been selected to represent IPS Academy at the 33rd International Management Conclave, scheduled for February 28, 2026 at the Brilliant Convention, Indore.

    This elite gathering will bring together distinguished academicians, educationists and top industry leaders. Ms. Urvashi will share the podium with eminent management experts and guest speakers, showcasing her prowess on critical topic entitled “Innovating India: Swadeshi, Swabhavik and Swanirmit”, shaping the future of business and leadership.

    Principal Dr. S.L. Kale expressed immense pride, stating, “Urvashi’s triumph over 25 top colleges exemplifies the caliber of talent we nurture and her platform at the International Management Conclave will elevate IPS Academy’s global presence.” Vice-Principal Dr. Gagan Prakash, President of IPS Group of Institutions Ar. Achal K. Choudhary and Management Member Er. Rajesh Choudhary warmly congratulated Ms. Urvashi affirming the institution’s dedication to fostering such excellence.

    The achievement underscores IPS Academy’s North Campus, commitment to nurturing communication skills and leadership talent among students, positioning the institution as a hub for excellence in management education.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.